Trial intelligence / Profile preview

Hydrocortisone pharmacokinetics and ACTH-guided dose titration in adults with Addison's disease

2007-005170-30Phase 2Completed

Sponsor
CHU Caen Normandie
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of hydrocortisone in Addison's disease, sponsored by CHU Caen Normandie. Primary endpoints: Plasma ACTH and cortisol profiling over the day, Cortisol area under the curve for each hydrocortisone dose and 3 more. Started Oct 2007; status: completed.

02

Drugs

hydrocortisone
03

Conditions

Addison's disease

Beyond the preview

Go deeper on 2007-005170-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005170-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call